Experimental and Computational Structural Studies of 2,3,5-Trisubstituted and 1,2,3,5-Tetrasubstituted Indoles as Non-Competitive Antagonists of GluK1/GluK2 Receptors.

Molecules

Pharmaceutical Substances with Computer Modeling Laboratory, Department of Synthesis and Chemical Technology, Faculty of Pharmacy, Medical University of Lublin, 4A Chodźki St., PL-20093 Lublin, Poland.

Published: April 2022


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

The blockade of kainate receptors, in particular with non-competitive antagonists, has-due to their anticonvulsant and neuroprotective properties-therapeutic potential in many central nervous system (CNS) diseases. Deciphering the structural properties of kainate receptor ligands is crucial to designing medicinal compounds that better fit the receptor binding pockets. In light of that fact, here, we report experimental and computational structural studies of four indole derivatives that are non-competitive antagonists of GluK1/GluK2 receptors. We used X-ray studies and Hirshfeld surface analysis to determine the structure of the compounds in the solid state and quantum chemical calculations to compute HOMO and LUMO orbitals and the electrostatic potential. Moreover, non-covalent interaction maps were also calculated. It is worth emphasizing that compounds and are achiral molecules crystallising in non-centrosymmetric space groups, which is a relatively rare phenomenon.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032324PMC
http://dx.doi.org/10.3390/molecules27082479DOI Listing

Publication Analysis

Top Keywords

non-competitive antagonists
12
experimental computational
8
computational structural
8
structural studies
8
antagonists gluk1/gluk2
8
gluk1/gluk2 receptors
8
studies 235-trisubstituted
4
235-trisubstituted 1235-tetrasubstituted
4
1235-tetrasubstituted indoles
4
indoles non-competitive
4

Similar Publications

Functional ultrasound imaging (fUSI) is a cutting-edge technology that measures changes in cerebral blood volume (CBV) by detecting backscattered echoes from red blood cells moving within its field of view (FOV). It offers high spatiotemporal resolution and sensitivity, allowing for detailed visualization of cerebral blood flow dynamics. While fUSI has been utilized in preclinical drug development studies to explore the mechanisms of action of various drugs targeting the central nervous system, many of these studies rely on predetermined regions of interest (ROIs).

View Article and Find Full Text PDF

Antibiotic resistance is considered to be one of the most complex health obstacles of our time. Methicillin-resistant (MRSA) represents a global health challenge due to its broad treatment resistance capacity, resulting in high mortality rates. The shikimate pathway (SP) is responsible for the biosynthesis of chorismate from glycolysis and pentose phosphate pathway intermediates.

View Article and Find Full Text PDF

The enzyme γ-glutamyl transpeptidase (GGT), located on the surface of cellular membranes, hydrolyzes extracellular glutathione (GSH) to guarantee the recycling of cysteine and maintain intracellular redox homeostasis. High expression levels of GGT on tumor cells are associated with increased cell proliferation and resistance against chemotherapy. Therefore, GGT inhibitors have potential as adjuvants in treating GGT-positive tumors; however, most have been abandoned during clinical trials due to toxicity.

View Article and Find Full Text PDF

New and emerging pharmacologic treatments for MDD.

Front Psychiatry

August 2025

Standardization of Computational Anatomy Techniques for Cognitive and Behavioral Sciences (SoCAT) Lab, Department of Psychiatry, Faculty of the Medicine, Ege University, Izmir, Türkiye.

Major depressive disorder (MDD) presents a significant global health challenge, characterized by a high prevalence and significant impact on quality of life. Traditional antidepressants fall short in terms of efficacy and onset speed, up to 60% of patients. This review delves into the new and emerging pharmacologic treatments for MDD, focusing on their mechanisms of action, clinical effectiveness, and potential to fill the gaps left by conventional therapies.

View Article and Find Full Text PDF

Comprehensive kinetic characterization and inhibitor study of Ribonuclease E, a key enzyme of RNA metabolism from Mycobacterium smegmatis.

Int J Biol Macromol

September 2025

Molecular Microbiology Laboratory, Department of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi UP-221005, India. Electronic address:

Ribonuclease E (RNase E) in Mycobacterium species is an essential gene that plays a crucial role in RNA metabolism. This is the first detailed kinetic characterization of recombinant RNase E and its deletion mutants, along with virtual high-throughput ligand screening (vHTS) and in vitro inhibitor studies from any Mycobacterium species. Recombinant wild-type RNase E and its deletion mutants of Mycobacterium smegmatis (M.

View Article and Find Full Text PDF